You have read all your free articles, to continue reading subscribe to read the rest of this content.
Oasmia Pharmaceutical has announced the appointments of Kia Bengtsson as Head of Clinical Development and Johanna Röstin as Head of Regulatory Affairs with effect from October 1, 2021. The appointments strengthen Oasmia’s internal drug development expertise as the company progresses its portfoAlready a subscriber Login You have read all your…
AstraZeneca announced that Robert Iannone would be taking over its immuno-oncology drug development operations, a little more than a month after former senior vice president and head of immuno-oncology Rachel Humphrey left the company for undisclosed personal reasons at the end of November 2014. At Already a subscriber Login You…
OssDsign announces that its CFO Claes Lindblad is leaving the company in order to pursue other opportunities. A leading international recruitment firm has been engaged to lead the search process for a new CFO states OssDsign. Anders Svensson will take up the position as interim CFO as of Monday NAlready…
AlzeCure Pharma has announced the appointment of Märta Segerdahl, MD, PhD, Associate professor, as Chief Medical Officer (CMO). Segerdahl will be a member of AlzeCure’s executive management team and succeeds An van Es-Johansson, MD, currently CMO and Head of Development, and previously member Already a subscriber Login You have read…
